Chen Lin's Profile

Role	Title	Level	Year	L/R
🐜	Value of diffusion-weighted MRI for assessing liver fibrosis and cirrhosis. 7 auth. K. Sandrasegaran, F. Akisik, Chen Lin, B. Tahir, J. Rajan, R. Saxena, ... A. Aisen	7	2009	7 🐜
🐜	Usefulness of diffusion-weighted imaging in the evaluation of renal masses. 7 auth. K. Sandrasegaran, C. Sundaram, R. Ramaswamy, F. Akisik, M. Rydberg, Chen Lin, ... A. Aisen	7	2010	7 🐜
🐜	Assessment of chronic pancreatitis: utility of diffusion-weighted MR imaging with secretin enhancement. 8 auth. M. Akisik, A. Aisen, K. Sandrasegaran, S. G. Jennings, Chen Lin, S. Sherman, ... John A. Lin, M. Rydberg	6	2009	6 🐜
🐬	State-of-the-art pancreatic MRI. K. Sandrasegaran, Chen Lin, F. Akisik, M. Tann	6	2010	6 🐬
🐬	Pancreatic cancer: utility of dynamic contrast-enhanced MR imaging in assessment of antiangiogenic therapy. M. Akisik, K. Sandrasegaran, G. Bu, Chen Lin, Gary D. Hutchins, E. Chiorean	6	2010	6 🐬
🐜	Regional reproducibility of pulsed arterial spin labeling perfusion imaging at 3T 8 auth. Yang Wang, A. Saykin, J. Pfeuffer, Chen Lin, K. Mosier, Li Shen, ... Sungeun Kim, G. Hutchins	6	2011	6 🐜
🐬	The value of diffusion-weighted imaging in characterizing focal liver masses. K. Sandrasegaran, F. Akisik, Chen Lin, B. Tahir, J. Rajan, A. Aisen	6	2009	6 🐬
🐬	T1 mapping for diagnosis of mild chronic pancreatitis T. Tirkes, Chen Lin, E. Fogel, S. Sherman, Qiu-shi Wang, K. Sandrasegaran	6	2017	6 🐬
🐬	Abdominal MR imaging at 3.0 T. F. Akisik, K. Sandrasegaran, A. Aisen, Chen Lin, C. Lall	6	2007	6 🐬
🐢	Development and evaluation of TWIST Dixon for dynamic contrast‐enhanced (DCE) MRI with improved acquisition efficiency and fat suppression Yuan Le, R. Kroeker, H. Kipfer, Chen Lin	5	2012	5 🐢